Affiliation:
1. Department of Family Medicine and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Abstract
To mitigate COVID-19 exposure risks in methadone clinics, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a temporary modification of regulations in March 2020 to permit, with state concurrence, extended take-home methadone doses. The modification allowed for up to 28 days of take-home methadone for stable patients and 14 days for those less stable. Using both interrupted time series and difference-in-differences methods, this study examined the association between the policy change and fatal methadone overdoses, comparing states that permitted the expansion of take-home doses with states that did not. The findings suggest the pandemic emergency take-home policy did not increase methadone-involved mortality.
Funder
national institute on drug abuse
Reference19 articles.
1. Substance Abuse and Mental Health Services Administration. Methadone take-home flexibilities extension guidance. Accessed March 3, 2022. https://www.samhsa.gov/medication-assisted-treatment/statutes-regulations-guidelines/methadone-guidance
2. Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics System, CDC WONDER Online Database. Data are from the multiple cause of death files as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program. http://wonder.cdc.gov.
3. A Comprehensive set of Postestimation Measures to Enrich Interrupted Time-series Analysis
4. Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19